World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
16455
World Ranking
12350
National Ranking
953

Overview

Mary Frances McMullin is affiliated with Queen's University Belfast in the United Kingdom. Their research spans multiple disciplines within medicine, with particular focus on hematology, genetics, and molecular biology.

The main fields of study for McMullin include Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, their work extends into specialized subfields such as Genetics, Hematology, Molecular Biology, Rheumatology, and Immunology.

Their research topics cover several key areas related to blood disorders and treatments. The primary topics include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Kruppel-like factors research
  • Chronic Myeloid Leukemia Treatments
  • Eosinophilic Disorders and Syndromes
  • Hemoglobinopathies and Related Disorders
  • Acute Lymphoblastic Leukemia research

McMullin has contributed to multiple papers across prominent journals. Notable recent publications are:

  • "Protein tyrosine phosphatase receptor type C (PTPRC or CD45)", 2021, Journal of Clinical Pathology
  • "Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial", 2023, Journal of Clinical Oncology
  • "Molecular pathogenesis of the myeloproliferative neoplasms", 2021, Journal of Hematology & Oncology
  • "Significance of NPM1 Gene Mutations in AML", 2021, International Journal of Molecular Sciences
  • "FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML", 2023, Leukemia

The most frequent venues for McMullin's publications include:

  • Blood
  • British Journal of Haematology
  • Journal of Clinical Oncology
  • Leukemia
  • Irish Journal of Medical Science (1971 -)

Frequent collaborators in McMullin's work are:

  • Claire Harrison
  • Adam J. Mead
  • Ruben A. Mesa
  • Steven Knapper
  • Vikas Gupta

Best Publications

  • JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

    Linda M. Scott;Wei Tong;Ross L. Levine;Mike A. Scott

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment†‡

    Alan Kenneth Burnett;Donald Milligan;Archie G. Prentice;Anthony H. Goldstone

  • Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

    Jacob Grinfeld;Jyoti Nangalia;E Joanna Baxter;David C Wedge

  • Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

    Alan K Burnett;Nigel H Russell;Robert Kerrin Hills;David Bowen

  • Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

    Mary F. McMullin;D. Bareford;P. Campbell;A. R. Green

  • Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Jenny C. Taylor;Jenny C. Taylor;Hilary C. Martin;Stefano Lise;John Broxholme

  • A gain-of-function mutation in the HIF2A gene in familial erythrocytosis

    Melanie J. Percy;Paul W. Furlow;Guy S. Lucas;Xiping Li

  • A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis

    Melanie J. Percy;Quan Zhao;Adrian Flores;Claire Harrison

  • Guideline for investigation and management of adults and children presenting with a thrombocytosis

    Claire N. Harrison;David Bareford;Nauman Butt;Peter Campbell

  • Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm

    Philip A. Beer;François Delhommeau;Jean-Pierre LeCouédic;Mark A. Dawson

  • Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

    Francesco Passamonti;Chiara Elena;Susanne Schnittger;Radek C. Skoda

  • Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial

    Alan Kenneth Burnett;Robert Kerrin Hills;Donald W. Milligan;Anthony H. Goldstone

  • How common are myeloproliferative neoplasms? A systematic review and meta-analysis

    Glen J Titmarsh;Andrew S Duncombe;Mary Frances McMullin;Michael O'Rorke

  • Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology.

    T G Smith;J T Brooks;G M Balanos;T R Lappin

  • Regulation of human metabolism by hypoxia-inducible factor

    Federico Formenti;Dumitru Constantin-Teodosiu;Yaso Emmanuel;Jane Cheeseman

  • The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

    Alan Kenneth Burnett;Donald Milligan;Anthony Goldstone;Archibald Prentice

  • A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.

    Melanie J. Percy;Paul W. Furlow;Philip A. Beer;Terence R. J. Lappin

  • European Development of Clofarabine as Treatment for Older Patients With Acute Myeloid Leukemia Considered Unsuitable for Intensive Chemotherapy

    Alan K Burnett;Nigel Russell;W Jonathan Kell;Michael Dennis

  • Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis.

    Melanie J. Percy;Philip A. Beer;Gavin Campbell;Ad W. Dekker

Frequent Co-Authors

Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Anthony R. Green
Anthony R. Green University of Cambridge
Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
Alan Kenneth Burnett
Alan Kenneth Burnett University of Glasgow
Nigel H. Russell
Nigel H. Russell University of Nottingham
Frank S. Lee
Frank S. Lee University of Pennsylvania
Amylou C. Dueck
Amylou C. Dueck Mayo Clinic
Donald Milligan
Donald Milligan University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to diverse, rewarding career paths. Students seeking flexible education options may also consider online degree programs in related fields. For those fascinated by human performance and body mechanics, a sports science degree online offers a comprehensive look into fitness, health, and rehabilitation, making it ideal for aspiring coaches or wellness professionals.

If you want to advance quickly, programs like an accelerated kinesiology degree online enable students to fast-track their expertise in movement science and exercise physiology. For those with a passion for healthcare, specialized certificate programs can lead to high-demand nursing roles. The shortest pmhnp program streamlines the path to psychiatric mental health nurse practitioner certification, while the 1 year post master's fnp online program helps current nurses swiftly qualify as family nurse practitioners.

Whether you’re interested in research, clinical practice, or sports health, these online and accelerated programs provide flexible routes to rewarding roles in the science and healthcare fields.

Best Scientists Citing Mary Frances McMullin

Trending Scientists